These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3339376)

  • 41. Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study.
    Lin HC; Daimon M; Wang CH; Ho Y; Uang YS; Chiang SJ; Wang LH
    Int J Cardiol; 2017 Apr; 233():85-90. PubMed ID: 28202260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden.
    Kapetanovic MC; Nilsson P; Turesson C; Englund M; Dalbeth N; Jacobsson L
    Arthritis Res Ther; 2018 Aug; 20(1):190. PubMed ID: 30157929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.
    Jousilahti P; Vartiainen E; Tuomilehto J; Puska P
    Circulation; 1999 Mar; 99(9):1165-72. PubMed ID: 10069784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type A behavior and the ten year incidence of coronary heart disease in the Framingham Heart Study.
    Haynes SG; Feinleib M; Eaker ED
    Act Nerv Super (Praha); 1982; Suppl 3(Pt 1):57-77. PubMed ID: 7183081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible angina detected by the WHO angina questionnaire in apparently healthy men with a normal exercise ECG: coronary heart disease or not? A 26 year follow up study.
    Bodegard J; Erikssen G; Bjornholt JV; Thelle D; Erikssen J
    Heart; 2004 Jun; 90(6):627-32. PubMed ID: 15145862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.
    Menotti A; Puddu PE; Lanti M
    Eur Heart J; 2000 Mar; 21(5):365-70. PubMed ID: 10666350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.
    Jenner JL; Ordovas JM; Lamon-Fava S; Schaefer MM; Wilson PW; Castelli WP; Schaefer EJ
    Circulation; 1993 Apr; 87(4):1135-41. PubMed ID: 8462142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease.
    Natarajan S; Liao Y; Cao G; Lipsitz SR; McGee DL
    Arch Intern Med; 2003 Jul; 163(14):1735-40. PubMed ID: 12885690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study).
    Galderisi M; Lauer MS; Levy D
    Am J Cardiol; 1992 Oct; 70(11):971-6. PubMed ID: 1414914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during 5 years of follow-up. The Zutphen Elderly Study.
    Weijenberg MP; Feskens EJ; Kromhout D
    Am J Epidemiol; 1996 Jan; 143(2):151-8. PubMed ID: 8546116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occurrence of gout in Copenhagen males aged 40-59.
    De Muckadell OB; Gyntelberg F
    Int J Epidemiol; 1976 Jun; 5(2):153-8. PubMed ID: 955764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Menopause and coronary heart disease. The Framingham Study.
    Gordon T; Kannel WB; Hjortland MC; McNamara PM
    Ann Intern Med; 1978 Aug; 89(2):157-61. PubMed ID: 677576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
    Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
    Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Community surveillance for coronary heart disease: the Framingham Cardiovascular Disease survey. Comparisons with the Framingham Heart Study and previous short-term studies.
    Margolis JR; Gillum RF; Feinleib M; Brasch R; Fabsitz R
    Am J Cardiol; 1976 Jan; 37(1):61-7. PubMed ID: 942677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relatively high coronary death and event rates in Turkish women. Relation to three major risk factors in five-year follow-up of cohort.
    Onat A; Dursunoğlu D; Sansoy V
    Int J Cardiol; 1997 Aug; 61(1):69-77. PubMed ID: 9292335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
    Albert MA; Glynn RJ; Ridker PM
    Circulation; 2003 Jul; 108(2):161-5. PubMed ID: 12835213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychosocial and other features of coronary heart disease: insights from the Framingham Study.
    Kannel WB; Eaker ED
    Am Heart J; 1986 Nov; 112(5):1066-73. PubMed ID: 3776801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.
    Choi HK; Atkinson K; Karlson EW; Curhan G
    Arch Intern Med; 2005 Apr; 165(7):742-8. PubMed ID: 15824292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. QRS interval fails to predict coronary disease incidence. The Framingham Study.
    Kreger BE; Anderson KM; Levy D
    Arch Intern Med; 1991 Jul; 151(7):1365-8. PubMed ID: 2064487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
    Kannel WB; Castelli WP; Gordon T; McNamara PM
    Ann Intern Med; 1971 Jan; 74(1):1-12. PubMed ID: 5539274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.